Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02344121

Intra- and Inter-fraction Changes in Radiation Therapy

Analysis to quantify intra-fraction, inter-fraction and post-treatment changes in tumor target volumes and surrounding normal organs in radiation therapy.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Sex eligibility

All sexes

Study type

Observational

Primary location

Froedtert Hospital

Milwaukee, Wisconsin, 53226, United States

Location status: Recruiting

Location contact

Eric Paulson, PhD

CONTACT

[email protected]

414-805-4400

Eric Paulson, PhD

PRINCIPAL_INVESTIGATOR

PhD

CONTACT

About this study

The accurate and detailed knowledge of the changes (e.g., anatomically/biologically intra- and inter-fraction changes) to be obtained from this study would allow the research team to determine how Adaptive Radiation Therapy (ART) should be performed for a given tumor site/type. Radiation oncologists then can choose a proper ART strategy for a given tumor type to account for the anatomic/biological intra- and inter-fraction changes, improving accuracy of radiation therapy delivery, and in turn reducing treatment related toxicities and/or improving tumor local control.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

°Completed radiation therapy

Exclusion criteria

°Subjects who refuse voluntary participation

Treatment and study plan

radiation therapy

Radiation

Radiation therapy plans for cancer patients who have completed treatment.

Primary outcomes

  1. Changes of volumes from baseline of organs at risk during and after radiation therapy.

    Time frame: 2 years

    Changes of organs at risk volumes (cm^3) during and after radiation therapy.

Secondary outcomes

  1. Changes of volumes from baseline or tumors during and after radiation therapy.

    Time frame: 2 years

    Changes of tumor volumes (cm^3) during and after radiation therapy.

Study contacts

Contact information is provided by the study sponsor or research team.

Eric Paulson, PhD

CONTACT

[email protected]

805-4400

Medical College of Wisconsin Cancer Center Clinical Trials Office

CONTACT

[email protected]

414-805-8900

Sponsors and collaborators

Lead sponsor

Medical College of Wisconsin

Other

Registry information

Important dates

Study start
2015
Primary completion
2027
Study completion
2028
First posted
Jan 22, 2015
Registry last updated
May 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.